Skip to main contentAll experts

DrAnn Livingstone

(She/Her)

Deakin University Post Doctoral Research Fellow

Faculty of Health/Institute for Health Transformation/Institute for Health Transformation

Orcid identifier0000-0002-6836-0382 (opens in a new tab)⁠
  • Deakin University Post Doctoral Research Fellow
    Faculty of Health/Institute for Health Transformation/Institute for Health Transformation
  • +61 3 9246 8725 (Work)
  • Melbourne Burwood Campus, 221 Burwood Highway, Burwood, Victoria 3125

RESEARCH INTERESTS

Health Economics
Discrete Choice Experiments (DCE)
Preference elicitation for healthcare interventions

Carers quality of life and impacts of caring 

Palliative care

Brain injury

GRANTS

  • GRANT
    FEATURED
    Featured
    Implementing evidence-based care for cognitive and psychosocial consequences of moderate-to-severe traumatic brain injury
    1 Jun 2024 - 31 May 2029
    People funded by this grant:
    • Ponsford J,
    • Honan C,
    • Bragge P,
    • Togher L,
    • Wong D
    MRFF Traumatic Brain Injury Grant - 2035165 - $29,200.00
  • GRANT
    FEATURED
    Featured
    The costs, benefits and patient and clinician preferences of adjuvant immunotherapy in melanoma (Health Economics)
    National Health and Medical Research Council1 Jan 2019 - 31 Dec 2021
    People funded by this grant:
    • Livingstone A
    NHMRC Postgraduate Scholarship (APP1168194)
  • FELLOWSHIP
    Developing methods to measure the preferences of people with intellectual disability and brain injury.
    Deakin University1 Apr 2026 - 31 Mar 2029
    People funded by this grant:
    • Livingstone A
  • COMPETITIVE GRANT
    Augmented versus face-to-face services for skin cancer diagnosis – Costs, benefits, and stakeholder preferences,
    MEDICAL RESEARCH FUTURE FUND (MRFF)1 Jun 2023 - 31 May 2027
    People funded by this grant:
    • Morton R,
    • Livingstone A,
    • Janda M,
    • Fernandez Peñas P,
    • Mar V
  • COMPETITIVE GRANT
    REZOLV3R: Randomised trial of palliative intraperitoneal bevacizumab following therapeutic drainage of recurrent malignant ascites in patients with chemotherapy resistant solid tumours
    Cancer Australia1 Jan 2023 - 31 Dec 2025
    People funded by this grant:
    • Sjoquist K,
    • Livingstone A,
    • Stockler M,
    • Friedlander M,
    • Francis K
  • COMPETITIVE GRANT
    The costs, benefits and patient and clinician preferences of adjuvant immunotherapy in melanoma (Health Economics)
    Melanoma Institute Australia Postgraduate Research Scholarships (top up)1 Jan 2019 - 31 Dec 2021
    People funded by this grant:
    • Livingstone A
  • COMPETITIVE GRANT
    The costs, benefits and patient and clinician preferences of adjuvant immunotherapy in melanoma (Health Economics)
    Sydney Catalyst1 Jan 2019 - 31 Dec 2020
    People funded by this grant:
    • Livingstone A
  • COMPETITIVE GRANT
    The costs, benefits and patient and clinician preferences of adjuvant immunotherapy in melanoma (Health Economics)
    NHMRC1 Jan 2019 - 31 Dec 2021
    People funded by this grant:
    • Livingstone A
  • COMPETITIVE GRANT
    ACED-Phase II rando placebo-controlled double-blind multi-site study of acetazolamide v placebo for management of cerebral oedema in recurrent, progressive HGG requiring dexamethasone treatment
    Cancer Australia1 Jan 2016 - 31 Dec 2018
    People funded by this grant:
    • Agar M
  • COMPETITIVE GRANT
    The PEARL trial: Palliative care Early in Advanced Lung Cancers
    Cancer Australia1 Jan 2016 - 31 Dec 2018
    People funded by this grant:
    • Mileshkin L,
    • Livingstone A
  • COMPETITIVE GRANT
    VERTU-Veliparib, Radiotherapy and Temozolomide trial in Unmethylated MGMT Glioblastoma
    Cancer Council NSW1 Jan 2016 - 31 Dec 2018
    People funded by this grant:
    • Khasraw M,
    • Livingstone A
  • COMPETITIVE GRANT
    Phase III trial on Concurrent and Adjuvant Temozolomide chemotherapy in non-1p/19q deleted anaplastic glioma. The CATNON Intergroup trial
    NHMRC1 Jan 2015 - 31 Dec 2017
    People funded by this grant:
    • Nowak A,
    • Livingstone A
  • COMPETITIVE GRANT
    VERTU-Veliparib, Radiotherapy and Temozolomide trial in newly diagnosed Unmethylated MGMT Glioblastoma
    Cure for Life1 Jan 2015 - 31 Dec 2017
    People funded by this grant:
    • Khasraw M,
    • Livingstone A
  • COMPETITIVE GRANT
    Cooperative Trials Group for Neuro-Oncology (COGNO) Grant
    Cancer Institute NSW1 Jan 2013 - 31 Dec 2015
    People funded by this grant:
    • Hovey E,
    • Livingstone A
  • COMPETITIVE GRANT
    Phase III trial on Concurrent and Adjuvant Temozolomide chemotherapy in non-1p/19q deleted anaplastic glioma. The CATNON Intergroup trial.
    Cancer Institute NSW1 Jan 2012 - 31 Dec 2014
    People funded by this grant:
    • Nowak A,
    • Livingstone A